This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

TESS Shoulder Arthroplasty Data Collection

This study is ongoing, but not recruiting participants.
Biomet France SARL
Information provided by (Responsible Party):
Zimmer Biomet Identifier:
First received: September 11, 2008
Last updated: March 9, 2017
Last verified: July 2016
This observational study intends to collect efficacy and safety data on TESS shoulder system


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Prospective, Multicentre Study Evaluating the Clinical Performance of the T.E.S.S Anatomic and Reverse Shoulder Prostheses

Further study details as provided by Zimmer Biomet:

Primary Outcome Measures:
  • Constance and oxford Scores [ Time Frame: 6m, 1yr, 2yr, 3yr, 4yr, 5 yr, 7yr and 10yr ]

Secondary Outcome Measures:
  • Complication [ Time Frame: Any time ]
  • Patient Satisfaction [ Time Frame: 6m,1yr,2yr,3yr,4yr, 5yr, 7yr and 10yr ]

Enrollment: 600
Study Start Date: January 2006
Estimated Study Completion Date: October 2020
Estimated Primary Completion Date: October 2020 (Final data collection date for primary outcome measure)
TESS prosthesis
Consecutive series of patients with a TESS prosthesis.

Detailed Description:
The T.E.S.S.® shoulder system has been developed to provide a complete solution for all the indications for Shoulder Arthroplasty, Arthritis, Rotator Cuff Arthropathy, Proximal Humeral Fracture, minimising bone resection and restoring the natural anatomy of the patient.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Consecutive series of patients received TESS prostheses

Inclusion Criteria:

  • A pre-operative level of pain and function the same as for conventional joint replacement
  • A likelihood of obtaining relief of pain and improved function
  • Full skeletal maturity
  • Ability to follow instructions
  • Good general health for age
  • Willing to return for follow-up evaluations

Exclusion Criteria:

  • Glenohumeral joint infection, osteomyelitis
  • Neuro-muscular complications
  • Inability to co-operate with and complete the study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00751673

De Dreef Van Zonnebos 13
Schilde, Belgium
Clinique Générale
Annecy, France
Institut Calot
Berck sur Mer, France
Polyclinique Jean Villar
Bruges, France
Clinique St Joseph
Chambery, France
Centre Hospitalier Général
Dax, France
Clinique Chirurgicale Orthopédique A.D.R.
Maxeville, France
Clinique St Jean
Montpellier, France
Paris, France
Clinique St Martin
Pessac, France
Polyclinique de l'Atlantique
Saint Herblain, France
Clinique Mutualiste
St Etienne, France
Institut A. Tzanck
St Laurent du Var, France
Sponsors and Collaborators
Zimmer Biomet
Biomet France SARL
Principal Investigator: Laurent BEGUIN, MD Clinique Mutualiste (Saint Etienne)
  More Information

Responsible Party: Zimmer Biomet Identifier: NCT00751673     History of Changes
Other Study ID Numbers: BMETEU.CR.EU74
Study First Received: September 11, 2008
Last Updated: March 9, 2017 processed this record on September 19, 2017